跳至主要内容
临床试验/NCT01532791
NCT01532791招募中不适用

Mitochondrial Encephalomyopathies and Mental Retardation: Investigations of Clinical Syndromes Associated With MtDNA Point Mutations

Columbia University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2004年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
MRI/MRS

研究概览

简要总结

Carriers of the m.3242A>G mutation often have clinical symptoms which can include migraines, seizures, strokes, hearing loss, balance issues, gastrointestinal issues, and many other symptoms. The investigators would like to learn more about these disorders and have designed a "Natural History Study" to monitor these conditions over time so that physicians and scientists can not only understand the problems that patients have, but work on developing treatments. The focus of the current work is to evaluate known mutation carriers of the m.3243A>G (mitochondrial DNA) and their maternal relatives (carrier status not a requirement for participation). Paternal relatives will serve as controls. This study involves no treatment.

详细描述

The purpose of this study is to investigate the neurological and biochemical consequences of the m.3243 A>G mutation. Mitochondria are the powerhouses of the cell and are controlled by nuclear genetic material (DNA) and mitochondrial (mt) DNA. Mitochondrial DNA mutations impair mitochondrial function, and cause cellular energy failure. These mutations, when present in high abundance, cause neurological signs and symptoms that are clinically obvious. The investigators hypothesize that these mutations, when present in lesser abundance, will cause measurable alterations in the patient's neuropsychological profile and cerebral energy profile. This study does not involve any experimental or approved therapy. The investigators will evaluate the patient's condition with blood/urine tests, neurological exam, MRI/MRS, questionnaires, motor skills functioning, serum and urine biomarkers, and genetic testing.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
4 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Known carrier of a the m.3243 A>G mitochondrial mutation, ,or Maternally related to someone who carries the m.3243A>G mitochondrial mutation.
  • A family member who is not maternally related to someone who carries the m.3243A>G mitochondrial mutation

排除标准

  • Younger than 4 years of age
  • No confirmed m.3243 A>G mitochondrial DNA mutation in the family.

研究组 & 干预措施

mtDNA mutation

m.3243 A>G carriers and their maternal relatives Other mutations in the mitochondrial genome may be included

Control

controls (people not maternally related to mutation carriers) Preference is for married in relatives

结局指标

主要结局

MRI/MRS

时间窗: 2-3 years

Evaluate structure and function in brain and muscle

次要结局

  • Biomarkers(2-3 years)
  • Mutation load(2-3 years)
  • Motor skills(2-3 years)
  • Cognitive function(2-3 years)
  • Clinical symptoms(2-3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michio Hirano, MD

Professor of Neurology

Columbia University

研究点 (1)

Loading locations...

相似试验